IRIS Accounts Production v25.2.0.378 14897267 Board of Directors 1.6.24 31.5.25 31.5.25 false true false false true false 8919 3089 8919 12008 8919 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh148972672024-05-31148972672025-05-31148972672024-06-012025-05-31148972672023-05-25148972672023-05-262024-05-31148972672024-05-3114897267ns15:EnglandWales2024-06-012025-05-3114897267ns14:PoundSterling2024-06-012025-05-3114897267ns10:Director12024-06-012025-05-3114897267ns10:PrivateLimitedCompanyLtd2024-06-012025-05-3114897267ns10:SmallEntities2024-06-012025-05-3114897267ns10:AuditExempt-NoAccountantsReport2024-06-012025-05-3114897267ns10:SmallCompaniesRegimeForDirectorsReport2024-06-012025-05-3114897267ns10:SmallCompaniesRegimeForAccounts2024-06-012025-05-3114897267ns10:FullAccounts2024-06-012025-05-3114897267ns10:Director2422024-05-3114897267ns10:Director2422024-06-012025-05-3114897267ns10:Director2422023-05-262024-05-3114897267ns10:Director2422025-05-3114897267ns10:Director2422024-05-3114897267ns10:Director22024-06-012025-05-3114897267ns10:RegisteredOffice2024-06-012025-05-3114897267ns5:CurrentFinancialInstruments2025-05-3114897267ns5:CurrentFinancialInstruments2024-05-3114897267ns5:Non-currentFinancialInstruments2025-05-3114897267ns5:Non-currentFinancialInstruments2024-05-3114897267ns5:ShareCapital2025-05-3114897267ns5:ShareCapital2024-05-3114897267ns5:RetainedEarningsAccumulatedLosses2025-05-3114897267ns5:RetainedEarningsAccumulatedLosses2024-05-3114897267ns5:MotorVehicles2024-06-012025-05-3114897267ns5:ComputerEquipment2024-06-012025-05-3114897267ns5:MotorVehicles2024-05-3114897267ns5:ComputerEquipment2024-05-3114897267ns5:MotorVehicles2025-05-3114897267ns5:ComputerEquipment2025-05-3114897267ns5:MotorVehicles2024-05-3114897267ns5:ComputerEquipment2024-05-3114897267ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2024-05-3114897267ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2024-06-012025-05-3114897267ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2025-05-3114897267ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2024-05-3114897267ns5:WithinOneYearns5:CurrentFinancialInstruments2025-05-3114897267ns5:WithinOneYearns5:CurrentFinancialInstruments2024-05-31148972671ns10:Director12024-05-31148972671ns10:Director12023-05-25148972671ns10:Director12024-06-012025-05-31148972671ns10:Director12023-05-262024-05-31148972671ns10:Director12025-05-31148972671ns10:Director12024-05-31
REGISTERED NUMBER: 14897267 (England and Wales)









MUMBLES HEALTH LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MAY 2025






MUMBLES HEALTH LIMITED (REGISTERED NUMBER: 14897267)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


MUMBLES HEALTH LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MAY 2025







DIRECTORS: Dr A S Bukhari
Dr Z A Shah





REGISTERED OFFICE: Station House
North Street
Havant
Hampshire
PO9 1QU





REGISTERED NUMBER: 14897267 (England and Wales)





ACCOUNTANTS: Morris Crocker
Chartered Accountants
Station House
North Street
Havant
Hampshire
PO9 1QU

MUMBLES HEALTH LIMITED (REGISTERED NUMBER: 14897267)

BALANCE SHEET
31 MAY 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,534 19,052

CURRENT ASSETS
Debtors 5 15,018 14,929
Cash at bank 313 31,935
15,331 46,864
CREDITORS
Amounts falling due within one year 6 16,435 17,640
NET CURRENT (LIABILITIES)/ASSETS (1,104 ) 29,224
TOTAL ASSETS LESS CURRENT
LIABILITIES

430

48,276

CREDITORS
Amounts falling due after more than one
year

7

-

(13,850

)

PROVISIONS FOR LIABILITIES (383 ) (4,763 )
NET ASSETS 47 29,663

CAPITAL AND RESERVES
Called up share capital 10 10
Retained earnings 37 29,653
SHAREHOLDERS' FUNDS 47 29,663

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MUMBLES HEALTH LIMITED (REGISTERED NUMBER: 14897267)

BALANCE SHEET - continued
31 MAY 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 September 2025 and were signed on its behalf by:





Dr A S Bukhari - Director


MUMBLES HEALTH LIMITED (REGISTERED NUMBER: 14897267)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2025

1. STATUTORY INFORMATION

Mumbles Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Motor vehicles - 25% on reducing balance
Computer equipment - 33.33% on cost

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to related parties and investments in non-puttable ordinary shares.

Trade and other debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, deposits with banks and other short-term highly liquid investments and bank overdrafts. In the balance sheet, bank overdrafts are shown within borrowings or current liabilities.

Trade and other creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


MUMBLES HEALTH LIMITED (REGISTERED NUMBER: 14897267)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4. TANGIBLE FIXED ASSETS
Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 June 2024 23,214 2,463 25,677
Additions - 699 699
Disposals (22,775 ) - (22,775 )
At 31 May 2025 439 3,162 3,601
DEPRECIATION
At 1 June 2024 5,804 821 6,625
Charge for year 82 1,054 1,136
Eliminated on disposal (5,694 ) - (5,694 )
At 31 May 2025 192 1,875 2,067
NET BOOK VALUE
At 31 May 2025 247 1,287 1,534
At 31 May 2024 17,410 1,642 19,052

MUMBLES HEALTH LIMITED (REGISTERED NUMBER: 14897267)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2025

4. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts or finance leases are as follows:
Motor
vehicles
£   
COST
At 1 June 2024 22,775
Disposals (22,775 )
At 31 May 2025 -
DEPRECIATION
At 1 June 2024 5,694
Eliminated on disposal (5,694 )
At 31 May 2025 -
NET BOOK VALUE
At 31 May 2025 -
At 31 May 2024 17,081

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors - 3,000
Other debtors 15,018 11,929
15,018 14,929

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 1 -
Taxation and social security 14,877 10,931
Other creditors 1,557 6,709
16,435 17,640

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Other creditors - 13,850

MUMBLES HEALTH LIMITED (REGISTERED NUMBER: 14897267)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2025

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the year ended 31 May 2025 and the period ended 31 May 2024:

2025 2024
£    £   
Dr A S Bukhari and Dr Z A Shah
Balance outstanding at start of year 8,919 -
Amounts advanced 3,089 8,919
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 12,008 8,919